Regeneron's BCMAxCD3 Bispecific Antibody (REGN5458) Shows Deep and Durable Responses in Patients with Heavily-pretreated Multiple Myeloma in Phase 1

  • Deepu Madduri

Press/Media

Period7 Dec 2020

Media coverage

1

Media coverage